InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Uihlein Richard E, 董事. Director active across 1 company, notably Galectin Therapeutics INC. In total, 8 filings have been published. Activity tracked since 24 January 2022. The latest transaction was filed on 31 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Uihlein Richard E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
2,550,932 股@ US$4.052.96% mcap9.1% 占其流量Common StockSEC:0001133416-26-000065:1
31,825,235 股@ US$3.0027.36% mcap83.8% 占其流量Common StockSEC:0001133416-26-000065:0
13,158 股@ US$3.040.5% 占其流量Common StockSEC:0001133416-26-000020:0
32,520 股@ US$1.230.5% 占其流量Common StockSEC:0001133416-25-000022:0
23,256 股@ US$1.720.5% 占其流量Common StockSEC:0001133416-24-000026:0
1,466,204 股@ US$5.0098.6% 占其流量Common StockSEC:0001133416-23-000075:0
36,036 股@ US$1.110.5% 占其流量Common StockSEC:0001133416-23-000008:0
17,677 股@ US$1.980.4% 占其流量Common StockSEC:0001133416-22-000043:0
8 条申报中的 8 条
About Uihlein Richard E
Uihlein Richard E is Administrateur at Galectin Therapeutics INC (XNAS). He has 8 filings in total, and the 8 sampled filings cover the period from 2022-02-08 to 2026-08-04, with the modal transaction nature listed as Attribution. The cumulative buy and sell amounts across these sampled filings are both EUR 0.
